Natural products modulate cell apoptosis: a promising way for treating endometrial cancer

Front Pharmacol. 2023 Jun 8:14:1209412. doi: 10.3389/fphar.2023.1209412. eCollection 2023.

Abstract

Endometrial cancer (EC) is a prevalent epithelial malignancy in the uterine corpus's endometrium and myometrium. Regulating apoptosis of endometrial cancer cells has been a promising approach for treating EC. Recent in-vitro and in-vivo studies show that numerous extracts and monomers from natural products have pro-apoptotic properties in EC. Therefore, we have reviewed the current studies regarding natural products in modulating the apoptosis of EC cells and summarized their potential mechanisms. The potential signaling pathways include the mitochondria-dependent apoptotic pathway, endoplasmic reticulum stress (ERS) mediated apoptotic pathway, the mitogen-activated protein kinase (MAPK) mediated apoptotic pathway, NF-κB-mediated apoptotic pathway, PI3K/AKT/mTOR mediated apoptotic pathway, the p21-mediated apoptotic pathway, and other reported pathways. This review focuses on the importance of natural products in treating EC and provides a foundation for developing natural products-based anti-EC agents.

Keywords: anti-cancer effects; apoptosis; endometrial cancer; natural products; signal pathway.

Publication types

  • Review

Grants and funding

This research was supported by the Xinglin Scholar Research Promotion Project of Chengdu University of TCM (Grant no. QJRC2021019), and NSFC (National Natural Science Foundation of China, Grant no. 82004415).